Ample upside room Another example that confirms that biotechs, when they succeed, 5-10x is always possible. Even more in our case, given how low we are.
It's just that we're starting 8x lower than the lowest on this chart (2005). So we have ample room to cover just to reach 1.5B$US.
https://companiesmarketcap.com/ionis-pharmaceuticals/marketcap/